Trademark: TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Mark Identification
TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Proof of use for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
We do not have any records of a proof of use for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG at this moment.
Click here to add a proof of use for TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Possible trademark infringements of TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Basic Information about TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
- Serial Number
- 87178937
- Filing Date
- 21 Sep 2016
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG on the blockchain with WikiTrademarks.io.
- First use of TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG anywhere
- TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG was first used on 18 May 2016 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG?
1. GENENTECH, INC. SOUTH SAN FRANCISCO CA
2. GENENTECH, INC. SOUTH SAN FRANCISCO CA
Correspondent
- Robin Weatherhead
- 1 DNA WAY
- SOUTH SAN FRANCISCO CA 94080
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG